grant
Development of first-in-class selective plasmin inhibitor small molecules to address acute bleeding in trauma
Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Description preview
With the combined Innovate UK and investor support, ClotProtect will advance the development of a _first-in-class_, highly selective intravenous administered anti-bleeding (anti-fibrinolytic) medicine to treat life-threatening bleeding in trauma, surgery and high-risk clinical settings. This innovation targets a critical unmet need: bleeding…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click